Krebs Biochemicals & Industries
56.58
-0.83(-1.45%)
Market Cap₹121.99 Cr
PE Ratio-4.47
IndustryHealthcare
Company Performance:
1D-1.45%
1M-17.82%
6M-26.53%
1Y-42.28%
5Y-48.98%
View Company Insightsright
More news about Krebs Biochemicals & Industries
25Jul 25
Krebs Biochemicals & Industries' MD & CEO Jitendra Shah Steps Down
Jitendra Shah, Managing Director, CEO, and Director of Krebs Biochemicals & Industries Limited, has announced his resignation effective August 7, 2025, citing personal reasons. The resignation letter was submitted on July 25, 2025. The company has informed BSE Limited and the National Stock Exchange of India Ltd about this development. No successor has been announced yet, with the board expected to address the transition in the upcoming meeting on August 7, 2025.
 no imag found
1 Year Returns:-42.28%
Industry Peers
Sun Pharmaceutical
1,704.60
(+0.56%)
Divis Laboratories
6,113.50
(+1.48%)
Torrent Pharmaceuticals
3,997.20
(+1.48%)
Cipla
1,342.50
(+0.94%)
Dr Reddys Laboratories
1,275.50
(+2.76%)
Lupin
2,196.80
(+1.06%)
Zydus Life Science
923.45
(+3.97%)
Mankind Pharma
2,081.90
(+1.05%)
Aurobindo Pharma
1,203.70
(+1.07%)
Alkem Laboratories
5,750.50
(+1.17%)